Merlin(TM).net Patient Care Network is First Cardiac Rhythm
ST. PAUL, Minn.--(BUSINESS WIRE)--April 18, 2007--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval of the Merlin.net Patient Care Network, (PCN), an Internet-based central repository for patient device data that enables physicians and clinicians to connect directly to their patients' stored device data at any time, from anywhere, that Internet access is available.
Merlin.net PCN collects data from implant procedures, remote transmissions and in-clinic follow-up sessions. With immediate access to patient information through the secure Merlin.net PCN website, physicians can monitor and assess patient device data and determine the level of care needed remotely. Patients can send data directly to physicians using Merlin.net PCN from the comfort of their own home via the currently available Housecall Plus(TM) portable transmitter. Merlin.net PCN supports all currently marketed Atlas(R) and Epic(R) family implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) device families in the United States.
Source: St. Jude Medical | News Releases